Versor Investments’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,058
Closed -$177K 843
2024
Q1
$177K Buy
+19,058
New +$223K 0.04% 629
2023
Q4
Sell
-18,123
Closed -$187K 796
2023
Q3
$187K Sell
18,123
-4,700
-21% -$54.4K 0.04% 596
2023
Q2
$299K Buy
22,823
+12,323
+117% +$151K 0.05% 424
2023
Q1
$117K Sell
10,500
-5,000
-32% -$49.4K 0.02% 672
2022
Q4
$131K Buy
+15,500
New +$147K 0.01% 669

Other funds holding LUNG

Versor Investments's LUNG Position: Q2 2024 in Review

Versor Investments sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 19,058 shares — an estimated $177K sold.

Versor Investments first reported a position in LUNG in Q4 2022 and held it in 5 quarters. The position peaked at $299K in Q2 2023. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Versor Investments reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Versor Investments sold 19,058 Pulmonx shares in Q2 2024, an estimated $177K.
  • Versor Investments first reported a position in Pulmonx in Q4 2022 and held it in 5 quarters.
  • Versor Investments's Pulmonx position peaked at $299K in Q2 2023.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Versor Investments's 13F filing for Q2 2024, filed 1 Aug 2024.